Presentation is loading. Please wait.

Presentation is loading. Please wait.

Diagnosis, risk classification, and recommended management of a BRUE

Published byBella Rosenberg Modified over 6 years ago

Similar presentations

Presentation on theme: "Diagnosis, risk classification, and recommended management of a BRUE"— Presentation transcript:

1 Diagnosis, risk classification, and recommended management of a BRUE
Diagnosis, risk classification, and recommended management of a BRUE. *See Tables 3 and 4 for the determination of an appropriate and negative FH and PE. **See Fig 2 for the AAP method for rating of evidence and recommendations. Diagnosis, risk classification, and recommended management of a BRUE. *See Tables 3 and 4 for the determination of an appropriate and negative FH and PE. **See Fig 2 for the AAP method for rating of evidence and recommendations. CSF, cerebrospinal fluid; FH, family history; PE, physical examination; WBC, white blood cell. Joel S. Tieder et al. Pediatrics doi: /peds ©2016 by American Academy of Pediatrics

Download ppt "Diagnosis, risk classification, and recommended management of a BRUE"

Similar presentations

Fig. 4-1, p. 107. Fig. 4-2, p. 109 Fig. 4-3, p. 110.

Fig. 4-1, p Fig. 4-2, p. 109 Fig. 4-3, p. 110.
Slide 1Fig. 22.1, p.669. Slide 2Fig. 22.3, p.670.

Slide 1Fig. 22.1, p.669. Slide 2Fig. 22.3, p.670.
Teaching NeuroImages Neurology Resident and Fellow Section © 2013 American Academy of Neurology Neonatal Parechovirus Encephalitis: Typical MRI findings.

Teaching NeuroImages Neurology Resident and Fellow Section © 2013 American Academy of Neurology Neonatal Parechovirus Encephalitis: Typical MRI findings.
Slide 1Fig. 17.1, p.513. Slide 2Table 17.1, p.514.

Slide 1Fig. 17.1, p.513. Slide 2Table 17.1, p.514.
P.464. Table 13-1, p.465 Fig. 13-1, p.466 Fig. 13-2, p.467.

P.464. Table 13-1, p.465 Fig. 13-1, p.466 Fig. 13-2, p.467.
Fig. 11-1, p. 359. p. 360 Fig. 11-2, p. 361 Fig. 11-3, p. 361.

Fig. 11-1, p p. 360 Fig. 11-2, p. 361 Fig. 11-3, p. 361.
Table 6-1, p. 161. Fig. 6-1, p. 162 p. 163 Fig. 6-2, p. 164.

Table 6-1, p Fig. 6-1, p. 162 p. 163 Fig. 6-2, p. 164.
P. 192. Fig. 6-1, p. 193 Fig. 6-2, p. 193 Fig. 6-3, p. 195.

P Fig. 6-1, p. 193 Fig. 6-2, p. 193 Fig. 6-3, p. 195.
Figure 1.1 The observer in the truck sees the ball move in a vertical path when thrown upward. (b) The Earth observer views the path of the ball as a parabola.

Figure 1.1 The observer in the truck sees the ball move in a vertical path when thrown upward. (b) The Earth observer views the path of the ball as a parabola.
American Academy of Pediatrics, Committee on Infectious Diseases. Policy Updated Recommendations on the Use of Meningococcal Vaccines Pediatrics. doi:

American Academy of Pediatrics, Committee on Infectious Diseases. Policy Updated Recommendations on the Use of Meningococcal Vaccines Pediatrics. doi:
Fig. 6-CO, p. 184. p. 185a p. 185b p. 185c p. 185d.

Fig. 6-CO, p p. 185a p. 185b p. 185c p. 185d.
71-year-old Man with Nystagmus and Oscillpsia

71-year-old Man with Nystagmus and Oscillpsia
From: Assessment of the Accuracy of Procalcitonin to Diagnose Postoperative Infection after Cardiac Surgery Anesthes. 2007;107(2):232-238. doi:10.1097/01.anes.0000271871.07395.ad.

From: Assessment of the Accuracy of Procalcitonin to Diagnose Postoperative Infection after Cardiac Surgery Anesthes. 2007;107(2): doi: /01.anes ad.
Copyright © 2017 American Academy of Pediatrics.

Copyright © 2017 American Academy of Pediatrics.
Table 2. Cerebrospinal Fluid Analysis (CSF analysis)

Table 2. Cerebrospinal Fluid Analysis (CSF analysis)
Skin Appendage Disord 2018;4: DOI: /

Skin Appendage Disord 2018;4: DOI: /
Recommended Clinical Tests for the Evaluation of Rotator Cuff Disease

Recommended Clinical Tests for the Evaluation of Rotator Cuff Disease
Time to update guidelines on screening for latent tuberculosis infection in dermatologic patients being treated with tumor necrosis factor-alfa inhibitors 

Time to update guidelines on screening for latent tuberculosis infection in dermatologic patients being treated with tumor necrosis factor-alfa inhibitors 
Guidelines for phototherapy in hospitalized infants of 35 or more weeks’ gestation.Note: These guidelines are based on limited evidence and the levels.

Guidelines for phototherapy in hospitalized infants of 35 or more weeks’ gestation.Note: These guidelines are based on limited evidence and the levels.
CNS involvement in DLBCL

CNS involvement in DLBCL

Similar presentations

Ads by Google